CHICAGO - Gadopiclenol is emerging as an alternative gadolinium-based MRI contrast agent. To learn more about the product's potential, we spoke with Prof. Dr. Christiane Kuhl from the University Hospital Aachen in Germany at RSNA 2022.
Kuhl provides research update on gadolinium-based contrast agent
Dec 4, 2022
Latest in Market Analysis
SFR podcast features YouTube educator Mickaël Ohana
January 21, 2025
Stuart Taylor becomes BJR editor in chief (medical)
January 10, 2025
SERAM president-elect tackles workload and sustainability
January 10, 2025
SFR praises work of x-ray specialist Gabriel Kalifa
November 1, 2024